Overview To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy Status: Completed Trial end date: 2015-02-01 Target enrollment: Participant gender: Summary Phase 2 clinical study to evaluate of the efficacy and safety of DW1029M on microalbuminuria in Patients With Diabetic Nephropathy Phase: Phase 2 Details Lead Sponsor: Dong Wha Pharmaceutical Co. Ltd.